Drug Response

pharmacogenetic

Pharmacogenetic testing for guiding prescription of biologic medications? Myths vs reality

The escalating cost of biologic medications has private and public plan sponsors concerned. Many are turning to new technologies to stratify patient populations with the aim of reducing the total cost of biologics. Some providers are considering pharmacogenetic tests to guide selection of drug therapy. Others are looking at [...]

Read more...
medical cannabis

Cannabis – How can private health benefits plan sponsors and insurers make the right coverage decisions for plan members?

The legalization of cannabis poses a challenge for employers and insurers, as they are expected to cover the cost of medical cannabis as a part of their employee health benefits. A recent Deloitte report indicates that 7% of adult Canadian population are daily cannabis users, of which 29% are [...]

Read more...
nausea treatment

Cannabis for pain management: is it for everyone?

Among the recreational users, less than 30% of Cannabis is used for specific medical reasons, such as chronic pain management, nausea treatment, or anxiety and sleep. Source: A society in transition, an industry ready to bloom from Deloitte According to Health Canada, there are just under 300,000 registered medical cannabis users [...]

Read more...
Drug Metabolism and Aging

Drug Metabolism and Aging

Optimizing medications for older patients Prescribing for older patients can be challenging. Studies have shown that the elderly are more unpredictable in their response to both the benefits and adverse effects of medications. There are many biological processes that determine how the body reacts to a drug and each of these [...]

Read more...